An Overview of Current Recommendations and Options for the Management of Cancer Pain: A Comprehensive Review

Overview

Journal Oncol Ther

Specialty Oncology

Date 2020 Sep 7

PMID 32894414

Citations 12

Authors

Kyle L Gress

Karina Charipova

Alan D Kaye

Omar Viswanath

Ivan Urits

Affiliations

Soon will be listed here.

Abstract

It is estimated that one-third of oncologic patients in the USA do not receive analgesia proportional to or adequate for the intensity of their pain. A mechanism-based approach to oncologic pain therapy is critical to ensure that analgesia regimens are individualized and effective. Since the mechanisms that lead to cancer pain are complex, healthcare providers must be willing to elicit and recognize the symptoms of each individual patient since these factors influence both the experience of pain and response to treatment. This process is centered on the use of detailed history in order to understand symptom expression in the context of primary tumor diagnosis and progression, history of cancer pain, psychological distress, sleep disturbances, cognitive function, and addictive behavior. Incorporating all of these factors into the assessment of a patient's pain condition can facilitate management decisions and help predict patient response to treatment.

Citing Articles

Persistence of pain and suffering in cancer patients: challenges of pain management from the perspective of nurses.

Shahrbabaki P, Farokhzadian J, Ahmadi F, Khabbazzadeh F Front Pain Res (Lausanne). 2024; 5:1425036.

PMID: 39301326 PMC: 11410755. DOI: 10.3389/fpain.2024.1425036.

Remission after CAR T-cell therapy: Do lymphoma patients recover a normal life?.

Perthus A, Colin F, Charton E, Anota A, Lhomme F, Manson G Hemasphere. 2024; 8(5):e72.

PMID: 38803454 PMC: 11129324. DOI: 10.1002/hem3.72.

Application of a WeChat Mini Program to provide pharmaceutical care for cancer pain patients: A randomized controlled trial.

Zhao Q, Qiu X, Liu W, Nian Z, Chen T, Chen J Digit Health. 2024; 10:20552076241255654.

PMID: 38766359 PMC: 11100405. DOI: 10.1177/20552076241255654.

Infigratinib for the Treatment of Metastatic or Locally Advanced Cholangiocarcinoma With Known FGFR2 Gene Fusions or Rearrangements.

White K, Anwar A, Jin K, Bollich V, Kelkar R, Talbot N Cureus. 2023; 15(10):e46792.

PMID: 37954763 PMC: 10634393. DOI: 10.7759/cureus.46792.

Should oncologists trust cannabinoids?.

Creanga-Murariu I, Filipiuc L, Cuciureanu M, Tamba B, Alexa-Stratulat T Front Pharmacol. 2023; 14:1211506.

PMID: 37521486 PMC: 10373070. DOI: 10.3389/fphar.2023.1211506.

References

Liu W, Zheng Z, Tan K, Meredith G . Multidimensional Treatment of Cancer Pain. Curr Oncol Rep. 2017; 19(2):10. DOI: 10.1007/s11912-017-0570-0. View

Li X, Xiao W, Yang P, Zhao H . Psychological distress and cancer pain: Results from a controlled cross-sectional survey in China. Sci Rep. 2017; 7:39397. PMC: 5225451. DOI: 10.1038/srep39397. View

van den Beuken-van Everdingen M, de Rijke J, Kessels A, Schouten H, van Kleef M, Patijn J . Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007; 18(9):1437-49. DOI: 10.1093/annonc/mdm056. View

Magee D, Bachtold S, Brown M, Farquhar-Smith P . Cancer pain: where are we now?. Pain Manag. 2018; 9(1):63-79. DOI: 10.2217/pmt-2018-0031. View

Elliott J, Fallows A, Staetsky L, Smith P, Foster C, Maher E . The health and well-being of cancer survivors in the UK: findings from a population-based survey. Br J Cancer. 2011; 105 Suppl 1:S11-20. PMC: 3251954. DOI: 10.1038/bjc.2011.418. View

Knudsen A, Brunelli C, Kaasa S, Apolone G, Corli O, Montanari M . Which variables are associated with pain intensity and treatment response in advanced cancer patients?--Implications for a future classification system for cancer pain. Eur J Pain. 2010; 15(3):320-7. DOI: 10.1016/j.ejpain.2010.08.001. View

Wolfe J, Grier H, Klar N, LEVIN S, Ellenbogen J, Emanuel E . Symptoms and suffering at the end of life in children with cancer. N Engl J Med. 2000; 342(5):326-33. DOI: 10.1056/NEJM200002033420506. View

Korfage I, Essink-Bot M, Mols F, van de Poll-Franse L, Kruitwagen R, van Ballegooijen M . Health-related quality of life in cervical cancer survivors: a population-based survey. Int J Radiat Oncol Biol Phys. 2008; 73(5):1501-9. DOI: 10.1016/j.ijrobp.2008.06.1905. View

Schmidt B . The Neurobiology of Cancer Pain. J Oral Maxillofac Surg. 2015; 73(12 Suppl):S132-5. PMC: 5154550. DOI: 10.1016/j.joms.2015.04.045. View

10.

Glaser A, Fraser L, Corner J, Feltbower R, Morris E, Hartwell G . Patient-reported outcomes of cancer survivors in England 1-5 years after diagnosis: a cross-sectional survey. BMJ Open. 2013; 3(4). PMC: 3641492. DOI: 10.1136/bmjopen-2012-002317. View

11.

van den Beuken-van Everdingen M, Hochstenbach L, Joosten E, Tjan-Heijnen V, Janssen D . Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis. J Pain Symptom Manage. 2016; 51(6):1070-1090.e9. DOI: 10.1016/j.jpainsymman.2015.12.340. View

12.

Cleeland C, GONIN R, Baez L, Loehrer P, Pandya K . Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Intern Med. 1998; 127(9):813-6. DOI: 10.7326/0003-4819-127-9-199711010-00006. View

13.

Marin A, Martin M, Linan O, Alvarenga F, Lopez M, Fernandez L . Bystander effects and radiotherapy. Rep Pract Oncol Radiother. 2014; 20(1):12-21. PMC: 4268598. DOI: 10.1016/j.rpor.2014.08.004. View

14.

Grond S, Zech D, Diefenbach C, Radbruch L, Lehmann K . Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain. 1996; 64(1):107-114. DOI: 10.1016/0304-3959(95)00076-3. View

15.

Humble S, Dalton A, Li L . A systematic review of therapeutic interventions to reduce acute and chronic post-surgical pain after amputation, thoracotomy or mastectomy. Eur J Pain. 2014; 19(4):451-65. PMC: 4405062. DOI: 10.1002/ejp.567. View

16.

Klepstad P, Kaasa S, Cherny N, Hanks G, De Conno F . Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network. Palliat Med. 2005; 19(6):477-84. DOI: 10.1191/0269216305pm1054oa. View

17.

Caraceni A, Hanks G, Kaasa S, Bennett M, Brunelli C, Cherny N . Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012; 13(2):e58-68. DOI: 10.1016/S1470-2045(12)70040-2. View

18.

Breivik H, Cherny N, Collett B, De Conno F, Filbet M, Foubert A . Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol. 2009; 20(8):1420-33. DOI: 10.1093/annonc/mdp001. View

19.

Dowell D, Haegerich T, Chou R . CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. JAMA. 2016; 315(15):1624-45. PMC: 6390846. DOI: 10.1001/jama.2016.1464. View

20.

Schug S, Lavandhomme P, Barke A, Korwisi B, Rief W, Treede R . The IASP classification of chronic pain for ICD-11: chronic postsurgical or posttraumatic pain. Pain. 2018; 160(1):45-52. DOI: 10.1097/j.pain.0000000000001413. View